LSB Medical Technology Holding Group en SafeWell Group versterken de strategische samenwerking voor de productie van medische technologie

LSB MedTech Holding Group kondigt een strategische samenwerking aan met SafeWell Group Holdings (China) Co.. Deze samenwerking optimaliseert de productie en substantieel de betekenis van de hoogste internationale kwaliteitsnormen.

SafeWell Group is een wereldwijde pionier op het gebied van beveiliging en industriële productie. Het bedrijf heeft een hoofdkantoor van 66.700 vierkante meter in de regio Azië-Pacific. Daarnaast bezit het bedrijf SafeWell Global Hub, een functionele faciliteit van 120.060 vierkante meter in de Greater Economic Zone. SafeWell heeft productiefaciliteiten in Frankrijk, Duitsland, Turkije, de Verenigde Staten, het Verenigd Koninkrijk en Australië, daarnaast een productielocatie in Vietnam. Met meer dan 10 internationaal erkende merken en strategische samenwerkingen met Fortune Global 500-bedrijven en leiders in de beveiligingsindustrie, zet Safewell zich in voor innovatie en hoogwaardige productie.

Voor LSB MedTech betekent deze samenwerking een strategische uitbreiding van haar productiecapaciteit. Met een multidisciplinair team van biomedische ingenieurs en medisch specialisten is LSB MedTech gespecialiseerd in de ontwikkeling, patentering en wereldwijde licentieverlening van krachtige medische technologieën.

FlipProne XL App: Innovative Support for Prone & Supine Positioning

The FlipProne XL App was developed by LSB MedTech to support the use of the FlipProne XL system by healthcare professionals in hospitals, nursing homes, and disability care organizations. With this advanced application, the FlipProne XL evolves from a patient-turning system into a comprehensive platform designed to support Prone & Supine positioning procedures.

Communication between the app, the smart textile technology, and the system enables controlled and safely assisted patient positioning within the bed. The textile components of the smart sheet have been evaluated in multiple tests and studies to assess material performance and safety characteristics.

Prone & Supine positioning addresses the growing need for a safer and more efficient alternative to labor-intensive manual repositioning of patients in hospital and home-care beds. The FlipProne XL, in combination with the FlipProne XL App, supports several positioning methods, including:

  • Prone and supine positioning
  • Prone and supine positioning with continuous lateral rotation

CRO Division

Until July 2023, LSB MedTech Ltd (formerly Life Science Business Ltd) provided clinical research organization (CRO) services to pharmaceutical companies and the medical technology industry. These services included the design, execution, and analysis of clinical studies to support the development and regulatory approval of innovative pharmaceuticals and medical devices.

As of July 2023, the CRO laboratory activities have been acquired, allowing LSB MedTech to focus entirely on medical technology innovation, innovation consultancy, and intellectual property valorization.

Our Partner Aeonmed

Aeonmed operates three research and development centers located in Beijing, Shanghai, and Pennsylvania, USA. The company also has branch offices in Germany and Indonesia. Innovation is a fundamental pillar of Aeonmed’s corporate strategy and core competence.

By the end of 2016, Aeonmed had filed a total of 1,158 patents, including 747 invention patents. More than 30% of the company’s workforce is engaged in research and development. Annually, over 10% of total revenue is allocated to R&D, driving technological advancements and product innovation.

This website is intended exclusively for business-to-business (B2B) communication.
The information provided is aimed at professional partners, research institutions, healthcare organizations and companies involved in innovation, valorisation and technology development. It is not intended for patients or general consumer use.

Confidentiality Notice
Due to the confidential nature of our patents, inventions, and R&D activities, not all projects and development phases are publicly disclosed.

EU-office:
Coolsingel 104
3011 AG Rotterdam

info@lsbmedtech.nl